Insights

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

It soon becomes crunch time for an entrepreneurial start up with a ground-breaking idea in tough tech innovation. While exploring some of the details of CC’s workshop approach, Roger Mainwaring-Burton reveal the secrets of taking a product, service or company from benchtop to scale to success in the market…

Potential quantum attacks on government agencies and the military are part and parcel of the changing security landscape. In turn, government organizations are exploring the use of quantum for defense security, as well as the efficiencies of future states that these technologies will enable for mission-critical operations.

A meeting of minds - AI meets biology. This is the conversation that is bridging the gap between bioprocessing and machine learning.

What is quantum computing? That’s a question still being asked by much of the world’s C-suite. But here at CC our multidisciplinary teams of physicists, engineers and designers are already helping to plot a credible pathway for a future powered by quantum technologies…

When making a career move during the pandemic, I wondered whether it would be a risky decision during a time of such uncertainty. This fear was almost instantly swept away when I started working at Cambridge Consultants. My time at CC is flying by and having been a part of the consulting team for almost three years now, it’s been great to work with some fantastic consumer brands and companies.

The world of DNA testing is changing fast and the race is on to provide cheap, quick genetic diagnoses for patients. So what are the opportunities for companies working in this dynamic field?

Asia’s medical technology market is predicted to account for a third of global medical technology sales by 2025. As such, it's a hotbed for start-ups, so here are our six innovative start-ups to watch that are part of this year’s MedTech Innovator cohort. 

Global pharma is hitting a major fork in the road, and one way leads to failure. For me, it’s vital that the industry comes together to grasp the once-in-a-generation opportunity that emergent technology is offering.

Founders of early-stage start-ups are characteristically passionate, driven and optimistic. Understandably so. Very often they are nurturing a breakthrough idea with the capacity to disrupt business and change the world for the better. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong. 

Yan Lin Lye and a team from CC are embarking on a sequence of mentoring sessions as part of our commitment to MedTech Innovator Asia Pacific. For the second consecutive year, we're collaborating with the organisation to provide hands-on professional support to selected start-up participants.

The emergence of cell-based therapy's is one of the most important human stories of our time. Read our synthetic vision of affordable and accessible cell therapy for all...